Box score
Aviceda Therapeutics, Inc.
Reported $18.9M sold in a new Form D filed May 31, 2024 (Cambridge, Massachusetts).
- Biggest raise
- $18.9M filed May 31, 2024
- League
- Bio & Health Biotechnology
- Based in
- Cambridge, Massachusetts
- Season rank
- #231 of 1,389 in the Bio & Health League; #1081 of 12,443 overall (2024)
- Incorporated
- 2019
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2025-01-13 | Amendment | $75M | $207M | SEC |
| 2024-11-22 | New notice not ranked | $0 | $200M | SEC |
| 2024-05-31 | New notice | $18.9M | $27.7M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1824762.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Superluminal Medicines, Inc. | Bio & Health | $20M |
| 2 | Miach Orthopaedics Inc. | Bio & Health | $20M |
| 3 | Voyager Therapeutics, Inc. | Bio & Health | $20M |
| 4 | General Fluidics Corp | Bio & Health | $18.5M |
| 5 | Affini-T Therapeutics, Inc. rookie | Bio & Health | $17.6M |
| 6 | Naveris, Inc. | Bio & Health | $17.5M |